Acquiring Company
Lepu ScienTech Medical Technology (Shanghai) Ltd
Acquired Company
Shanghai Minwei Biotechnology Ltd
Description
Lepu ScienTech Medical Technology is acquiring a 54.2384% equity stake in Shanghai Minwei Biotechnology for RMB1.09 billion. This transaction is considered a major and connected deal requiring shareholder approval. The acquisition is part of Lepu's strategy to expand its role in biotechnology. Regulatory scrutiny is expected due to the connection with the controlling shareholder.
Don't miss Lepu ScienTech Medical Technology (Shanghai) Ltd's next move
Get an email the moment Lepu ScienTech Medical Technology (Shanghai) Ltd makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Shanghai Minwei Biotechnology Ltd?
Shanghai Minwei Biotechnology Ltd was acquired by Lepu ScienTech Medical Technology (Shanghai) Ltd, based in Shanghai. The deal was reported on August 22, 2026. Lepu ScienTech Medical Technology is a Hong Kong-listed group engaged in medical technologies. The company focuses on innovation and expansion in various health sectors. Lepu ScienTech Medical Technology (Shanghai) Ltd is privately held and operates in Health Care.
When did Lepu ScienTech Medical Technology (Shanghai) Ltd acquire Shanghai Minwei Biotechnology Ltd?
Lepu ScienTech Medical Technology (Shanghai) Ltd's acquisition of Shanghai Minwei Biotechnology Ltd was reported on August 22, 2026. Lepu ScienTech Medical Technology is acquiring a 54.2384% equity stake in Shanghai Minwei Biotechnology for RMB1.09 billion. This transaction is considered a major and connected deal requiring shareholder approval. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Shanghai Minwei Biotechnology Ltd do?
Shanghai Minwei Biotechnology Ltd is the company acquired in this transaction. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.